... >
organooxygen compound >
ester >
carboxylic ester >
lactone >
cyclodepsipeptide >
2-amino-4,6-dimethyl-3-oxo-n1,n9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
... >
organooxygen compound >
carbonyl compound >
carboxylic ester >
lactone >
cyclodepsipeptide >
2-amino-4,6-dimethyl-3-oxo-n1,n9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
organooxygen compound >
ester >
lactone >
cyclodepsipeptide >
2-amino-4,6-dimethyl-3-oxo-n1,n9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
organonitrogen compound >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
2-amino-4,6-dimethyl-3-oxo-n1,n9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
... >
organooxygen compound >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
2-amino-4,6-dimethyl-3-oxo-n1,n9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
amide >
primary amide >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
2-amino-4,6-dimethyl-3-oxo-n1,n9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic amino compound >
peptide >
depsipeptide >
cyclodepsipeptide >
2-amino-4,6-dimethyl-3-oxo-n1,n9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
organonitrogen compound >
organic amino compound >
peptide >
depsipeptide >
cyclodepsipeptide >
2-amino-4,6-dimethyl-3-oxo-n1,n9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
اصطلاح مرجح
2-amino-4,6-dimethyl-3-oxo-n1,n9-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
اینچی
-
InChI=1S/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)
اینچیکی
-
RJURFGZVJUQBHK-UHFFFAOYSA-N
اسمایلٓ
-
CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:125400
